Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T17:57:55.768Z.
Calculation as of: 2026-10-06T17:57:55.768Z.
Quote observation: 2026-10-06T17:54:29.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d00a9c235f8f3f2200d332a4911885706ef223ec632fccfa45bb3326c1a5dd06
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$97.39M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$97.40M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$102.21M
Free Cash Flow Yield
4.14%
TTM Avg
1.81%
3Y Avg
3.57%
5Y Avg
3.20%
Market Cap
$103.06M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.79M
Free Cash Flow Yield
N/A
TTM Avg
6.54%
3Y Avg
6.54%
5Y Avg
6.54%
Market Cap
$105.20M
Free Cash Flow Yield
27.15%
TTM Avg
25.60%
3Y Avg
13.86%
5Y Avg
9.06%
Market Cap
$92.33M
Free Cash Flow Yield
5381.70%
TTM Avg
1623.44%
3Y Avg
1623.44%
5Y Avg
1623.44%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PolyPid Ltd. (PYPD) | $98.66M | N/A | N/A | N/A | N/A |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $97.39M | N/A | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $97.40M | N/A | N/A | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $97.24M | N/A | N/A | N/A | N/A |
| The Joint Corp. (JYNT)vs › | $102.21M | 4.14% | 1.81% | 3.57% | 3.20% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $103.06M | N/A | N/A | N/A | N/A |
| Anixa Biosciences, Inc. (ANIX)vs › | $104.79M | N/A | 6.54% | 6.54% | 6.54% |
| Definitive Healthcare Corp. (DH)vs › | $105.20M | 27.15% | 25.60% | 13.86% | 9.06% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $92.33M | 5381.70% | 1623.44% | 1623.44% | 1623.44% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $103.68M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
